Initiator Pharma A/S
SSE:INIT.ST
Overview | Financials
Company Name | Initiator Pharma A/S |
Symbol | INIT.ST |
Currency | SEK |
Price | 8.08 |
Market Cap | 427,579,056 |
Dividend Yield | 0% |
52-week-range | 5 - 12.2 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Claus Elsborg Olesen |
Website | https://www.initiatorpharma.com |
An error occurred while fetching data.
About Initiator Pharma A/S
Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD